cushieblog.com
NDA for Macrilen™ for the Evaluation of Growth Hormone Deficiency in Adults
CHARLESTON, S.C.–(BUSINESS WIRE)–Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the “Company”) today announced that it has been notified by the U.S. Food and Drug Administration (“FDA…